跳至主要内容
临床试验/NCT02307071
NCT02307071Unknown4 期

Transcutaneous Suboccipital Neurostimulation for the Treatment of Chronic Migraine

University of Liege2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
4 期
入组人数
20
试验地点
2
主要终点
Monthly frequency of migraine days

研究概览

简要总结

This study evaluates the effect in chronic migraine patients of daily 20 minute-transcutaneous sub occipital neurostimulation using the occipital Cefaly° device.

详细描述

Chronic migraine is a disabling neurological condition affecting 0.5-2% of the population.

CM is difficult to treat and preventive treatment options are limited. Due to the inefficiency of available and the lack of new preventive anti-migraine drug, neurostimulation methods have raised great interest in recent years.

The ONSTIM study showed a reduction in headache frequency in 39% of patients treated with active ONS during 12 weeks, compared to no improvement in the "non-effectively" stimulated or medically treated groups.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of chronic migraine (ICHD III beta 1.3) with or without medication overuse

排除标准

  • other diseases

结局指标

主要结局

Monthly frequency of migraine days

时间窗: 2 months treatment

次要结局

  • Monthly frequency of headache days(2 months)
  • Monthly acute drug intake(2 months)
  • Monthly frequency of total headache days(2 months)
  • Cumulative monthly headache hours(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jean Schoenen

Honorary Full Professor

University of Liege

研究点 (2)

Loading locations...

相似试验